This book presents the advances in the investigation of CBRN events including deliberate acts of terrorism, accidental releases, or natural disasters.

The information such as identifying the type of CBRN agents used, determining their source and origin, assessing the extent of contamination, and linking the evidence to individuals or groups responsible for the incident is crucial for law enforcement, intelligence agencies, emergency responders, and policymakers in preventing future incidents, mitigating the effects              of              attacks,            and       ensuring           public  safety. The proposed book provides this information by presenting a comprehensive understanding of CBRN agents, their effects, and forensic techniques to detect and mitigate the effects. There is a lack of comprehensive information on tools for collection, preservation and analysis of CBRN forensic evidence which this book covers. The book presents case studies and practical examples illustrating the application of CBRN forensics in real-world scenarios. It provides insights into the indicators, patterns, and markers associated with CBRN incidents, enabling readers to identify potential threats, develop risk mitigation strategies, and enhance security measures.

The book serves as a valuable resource for professionals already working in the field of CBRN forensics, offering them updated information on emerging techniques, advancements, and best practices. It also targeted at first responders in emergency response such as fire-fighters, paramedics, law enforcement officers, government and military personnel responsible for CBRN defense and security, and policy makers involved in the development of strategies and operating procedures.

Dr. Navneet Sharma is working as an Assistant Professor in center for CBRN Mitigation at Amity Institute of Pharmacy, Amity University, Noida, India.  He has developed dermal formulation for CBRN decontamination of the skin and worked explicitly in the field of medical management of chemical, biological, radiological, and nuclear emergencies for the last five years. He won eight national and international prizes and have been granted ten patents, four of which are on CBRN decontamination technology and have been successfully transferred to the industries.

Dr. Rakhi Agarwal, is an Associate Professor and also Dean-Academics at National Forensic Sciences University (NFSU), Delhi Campus. She is a Forensic Chemist and Toxicologist with a career spanning more than 19 years. She completed M.Sc. Forensic Science from the Agra University (2003) and awarded with Ph.D. in Toxicology jointly from the CSIR-Indian Institute of Toxicology Research, Lucknow and Jamia Hamdard, New Delhi in 2008. She has to her credit 28 publications in peer reviewed international/national journals, 01 patent, 02 book chapters and 02 articles.

Dr. Rajesh Arora, is a Senior Scientist and Additional Director with the Government of India. His innovative contributions in the area of drug design and development and augmentation of medicinally useful secondary metabolites using biotechnological interventions have received wide international acclaim. Dr Arora was an expert member associated with the development of National Disaster Management Guidelines by the National Disaster Management Authority. He serves on the Editorial Boards of more than twenty-five international journals and is a reviewer for over hundred peer-reviewed journals.

Dr. Raman Chawla, Scientist ‘F’ at Institute of Nuclear Medicine and Allied Sciences, DRDO, has contributed in the development of National Disaster Management Guidelines for Chemical (Industrial), Biological emergencies, Medical Preparedness and Mass Casualty Management, and Chemical (Terrorism) Disaster Management. In his 15 years of experience in multidisciplinary fields ranging from drug development, disaster management to CBRN Mitigation, he has around 12 CBRN books/ manuals related to CBRN mitigation, around 120 publications/ chapters in journals/ books of international repute and 4 patents of formulations for treatment regimen in CBRN agents' attack to his credit.